This move is archived. Current quotes and coverage live on the stock page.
Follow AVCR
Avricore Health Inc's stock has taken a significant hit, dropping 15.38% in just one trading day.
In the latest trading session, Avricore Health Inc (AVCR.V) saw its stock price plummet to CA$0.06, marking a steep decline of 15.38%. This downturn raises questions about the company's current standing and future prospects, especially in light of its recent financial activities.
Avricore Health Inc
AVCR.V
AVCR.V
Avricore Health Inc
WealthAwesomeMarket cap
$6.32M
52W high
$0.10
52W low
$0.04
1W change
+11.11%
Beta
0.38
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCR's historical volatility
30-Day Vol
228.4%
Annualized
90-Day Vol
170.6%
Annualized
Trend (90d)
+0.0%
Annualized drift
90d Mean
C$0.05
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.05 | C$0.02 – C$0.11 |
| 60 trading days | C$0.05 | C$0.02 – C$0.15 |
| 90 trading days | C$0.05 | C$0.01 – C$0.20 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should be cautious as Avricore Health Inc faces significant volatility, reflecting broader concerns about its financial health and market strategy.
Stock Down 15.38% in One Day
Avricore Health Inc's market cap now stands at CA$6.95 million, reflecting investor concerns following a sharp decline in stock value.
Bull case
Despite the recent drop, Avricore has gained recognition for its innovative HealthTab™ platform and plans to expand into the UK market. This expansion could drive future growth and offer new opportunities for the company.
Bear case
The significant one-day loss might suggest deeper issues within the company. Investors may be skeptical about its funding strategies and market execution, which could hinder recovery efforts.
Recent Performance Overview
Avricore Health Inc's stock price has seen a dramatic decline of 15.38% in the last trading session, closing at CA$0.06. This drop has raised eyebrows among investors, particularly given the company's recent financing efforts aimed at expanding its HealthTab™ network.
Market Reactions and Investor Sentiment
The sharp decline in Avricore's stock may reflect broader investor concerns about the company's ability to execute its expansion plans effectively. With a market cap now at CA$6.95 million, the stock's performance could signal a lack of confidence in its future growth trajectory. Investors are advised to monitor developments closely, especially as the company navigates its expansion into the UK market.
Looking Ahead: What’s Next for Avricore?
As Avricore Health continues to pursue its UK expansion, the success of its HealthTab™ platform will be critical. Investors should consider both the potential for recovery and the risks associated with the company's current financial strategies. For more insights, check out our detailed analysis on Avricore Health Inc.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
